Beacon Pharmaceuticals (DHA:BEACONPHAR) Net Issuance of Debt : BDT5,257 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Beacon Pharmaceuticals Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Beacon Pharmaceuticals's net issuance of debt for the three months ended in Dec. 2023 was BDT2,125 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2023 was BDT5,257 Mil.

Beacon Pharmaceuticals Net Issuance of Debt Historical Data

The historical data trend for Beacon Pharmaceuticals's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beacon Pharmaceuticals Net Issuance of Debt Chart

Beacon Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Issuance of Debt

Get a 7-Day Free Trial

-1.58

396.43

315.79

1,329.78

3,628.33

Beacon Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Issuance of Debt	Get a 7-Day Free Trial															125.16	2,115.72	979.92	36.33	2,125.34

Beacon Pharmaceuticals Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT5,257 Mil.

Beacon Pharmaceuticals Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Beacon Pharmaceuticals's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Beacon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beacon Pharmaceuticals PLC (DHA:BEACONPHAR) » Definitions » Net Issuance of Debt

Traded in Other Exchanges

N/A

Address

9/B/2, Toyenbee Circular Road, Motijheel C/A, Beacon Business Centre, Dhaka, BGD, 1223

Website

https://www.beaconpharma.com.bd

Beacon Pharmaceuticals PLC manufactures and markets pharmaceutical products. Its products are used in various therapeutic areas, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, and muscle relaxants. The company exports its products to Europe, America, Australia, Africa, and Asia. The company's products can be segmented as General, Chronic Care, Oncology, and Biotech products.

Beacon Pharmaceuticals Headlines

No Headlines